Smart Use of Skin Biopsy Punch in Treating Keloids: A Single-Center Retrospective Study
Aesthetic Plastic Surgery · 2024
DOI: 10.1007/s00266-024-04000-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aesthetic Plastic Surgery, 2024. Verfasst von Yixin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xiangya Hospital, Central South University, No.81 Kaifu Road, Kaifu District, Changsha, 410008, Hunan Province, China. Hauptthemen laut MEDLINE: Keloid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Treatment of scarring has long been a problem due to high incidence and recurrence. Despite many existing treatment therapies, the efficacy remains unstable. OBJECTIVES: To determine the efficacy and safety of skin biopsy punch in combination with corticosteroid injection (BPCI) in treating keloids. APPROACH: This was a retrospective study. In total, 16 patients with keloids received BPCI. Changes in scar appearance, accompanied symptoms, and Vancouver Scar Scale (VSS) were analyzed. Patient satisfaction, VAS scores, and adverse effects were also evaluated. RESULTS: Scar appearance, accompanied symptoms, and VSS scores improved significantly after the treatment. The total effective rate was 93.75% at an 18-month follow-up on average. The mean reduction rate of VSS score was 58.44% (p < 0.0001), especially in height and pliability (84.44% and 78.19%, p < 0.0001). The recurrence rate in this study was 12.5% (n = 2) at an 18-month follow-up on average. Mild adverse effects of pain, pruritus, hypopigmentation, and telangiectasia were recorded. CONCLUSIONS: This study demonstrated BPCI might be an effective and safe therapy in keloids with a low long-time recurrence rate and well tolerance for patients. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these evidence-based medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Xiangya Hospital, Central South University, No.81 Kaifu Road, Kaifu District, Changsha, 410008, Hunan Province, China.
- National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
- Hunan Engineering Research Center of Skin Health and Disease, Central South University, Changsha, 410008, Hunan, China.
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
- Department of Dermatologic Surgery and Dermatologic Oncology, Dermatology Hospital of Southern Medical University, Guangdong Provincial Dermatology Hospital, 2 Lujing Road, Yuexiu District, Guangzhou, 510000, Guangdong…
ORCID-Profile: Renliang He
Zitieren
APA
Li, Y., Dong, J., Liu, L., Huang, K., Zhu, D., Zhu, W., Zhao, S., & He, R. (2024). Smart Use of Skin Biopsy Punch in Treating Keloids: A Single-Center Retrospective Study. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-024-04000-6
Vancouver
Li Y, Dong J, Liu L, Huang K, Zhu D, Zhu W, et al. Smart Use of Skin Biopsy Punch in Treating Keloids: A Single-Center Retrospective Study. Aesthetic Plastic Surgery. 2024. doi:10.1007/s00266-024-04000-6
BibTeX
@article{Li2024,
author = {Li, Yixin and Dong, Jingyi and Liu, Liuhong and Huang, Kai and Zhu, Dingheng and Zhu, Wu and Zhao, Shuang and He, Renliang},
title = {Smart Use of Skin Biopsy Punch in Treating Keloids: A Single-Center Retrospective Study},
journal = {Aesthetic Plastic Surgery},
year = {2024},
doi = {10.1007/s00266-024-04000-6}
}
EUVIMED